We are live on
!
Find out more
RLWM
RF&L Wealth Management Portfolio holdings
AUM
$134M
1-Year Est. Return
20.46%
This Fund
S&P 500
This Quarter
Est. Return
+7.39%
1 Year Est. Return
+20.46%
3 Year Est. Return
+62.32%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$170M
AUM Growth
+$15.2M
(+9.8%)
Cap. Flow
+$4M
Cap. Flow
% of AUM
2.35%
Top 10 Holdings %
Top 10 Hldgs %
50.9%
Holding
61
New
2
Increased
28
Reduced
12
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Costco
COST
|
+$1.92M |
| 2 |
Vanguard Short-Term Bond ETF
BSV
|
+$409K |
| 3 |
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
+$408K |
| 4 |
Dimensional International Value ETF
DFIV
|
+$233K |
| 5 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$221K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boston Scientific
BSX
|
+$215K |
| 2 |
AbbVie
ABBV
|
+$83.5K |
| 3 |
JPMorgan Chase
JPM
|
+$67.2K |
| 4 |
Dimensional US Core Equity 2 ETF
DFAC
|
+$49.6K |
| 5 |
Chevron
CVX
|
+$31K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.08% |
| 2 | Healthcare | 5.78% |
| 3 | Consumer Staples | 4.67% |
| 4 | Consumer Discretionary | 3.62% |
| 5 | Communication Services | 3.05% |
Similar funds
LEP
SWM
PA
LWM
TWA
WLG
RA
BAM
RF&L Wealth Management's Q3 2025 Portfolio in Review
As of Q3 2025, RF&L Wealth Management held 61 positions worth $170M, up 9.8% from $155M the previous quarter. Its ten largest holdings account for 51% of the portfolio.
Trading was light in Q3 2025: portfolio turnover was 4.9%. RF&L Wealth Management opened 2 new positions and exited 1, leaving the 61-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 12% a quarter earlier, followed by Healthcare and Consumer Staples.
- RF&L Wealth Management's largest Q3 2025 buy was State Street SPDR Bloomberg 1-3 Month T-Bill ETF: 4,455 shares worth $409K.
- RF&L Wealth Management added most to Costco in Q3 2025, an estimated $1.92M increase.
- RF&L Wealth Management's biggest Q3 2025 reduction was AbbVie, cutting an estimated $83.5K.
- RF&L Wealth Management fully exited Boston Scientific in Q3 2025, selling an estimated $215K.
- RF&L Wealth Management's ten largest holdings make up 51% of its $170M portfolio in Q3 2025.
- RF&L Wealth Management opened 2 new positions and closed 1 in Q3 2025.
- RF&L Wealth Management's portfolio value rose 9.8% quarter-over-quarter to $170M.
Based on RF&L Wealth Management's 13F filing for Q3 2025, filed 8 Oct 2025.